Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 4, 2007, Pages 213-218

  Akaishi, J ^a   Onda, M ^a   Okamoto, J ^a   Miyamoto, S ^a   Nagahama, M ^b   Ito, K ^b   Yoshida, A ^c   Shimizu, K ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b ITO HOSPITAL   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

Author keywords

Anaplastic thyroid cancer; cDNA microarray; Gene expression; Molecular marker; TMEM34

Indexed keywords

MEMBRANE PROTEIN; TRANSMEMBRANE PROTEIN 34; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CARCINOGENESIS; CELL GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

CARCINOMA; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; THYROID NEOPLASMS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33846975114     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0159-8     Document Type: Article

References (19)

1. Demeter JG, De Jong SA, Lawrence AM, Paloyan E (1991) Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 110:956-961
2. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL (1999) Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59:1811-1815
3. Hu J, Jiang C, Ng HK, Pang JC, Tong CY, Chen S (2003) Genome-wide allelotype study of primary glioblastoma multiforme. Chin Med J (Engl) 116:577-583
4. Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M (2000) Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Genes Chromosomes Cancer 27:244-251
5. Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159-164
6. Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A (1997) p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 14:729-740
7. Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I, Takai S (1992) p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83:1293-1298
8. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404
9. Onda M, Emi M, Yoshida A, Miyamoto S, Akaishi J, Asaka S, Mizutani K, Shimizu K, Nagahama M, Ito K, Tanaka T, Tsunoda T (2004) Comprehensive gene-expression profiling of anaplastic thyroid cancers with cDNA microarray of 25,344 genes. Endocr Relat Cancer 11:843-854
10. Onda M, Akaishi J, Asaka S, Okamoto J, Miyamoto S, Mizutani K, Yoshida A, Ito K, Emi M (2005) Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. Br J Cancer 92:2216-2224
11. Passler C, Scheuba C, Prager G, Kaserer K, Flores JA, Vierhapper H, Niederle B (1999) Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg 384:284-293
12. Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X (2005) Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 103:2261-2268
13. Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX, Yu XJ, Li JT, Hu LF, Ernberg I, Zeng YX (2000) Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 17:1267-1275
14. Smith LL, Coller HA, Roberts JM (2003) Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5:474-479
15. Stringer BM, Rowson JM, Parkar MH, Seid JM, Hearn PR, Wynford-Thomas D, Ingemansson S, Woodhouse N, Goyns MH (1989) Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas. Experientia 15:372-376
16. Suarez HG (1998) Genetic alterations in human epithelial thyroid tumours. Clin Endocrinol (Oxf) 48:531-546
17. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA (1990) Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66:321-330
18. Wiseman SM, Loree TR, Rigual NR, Hicks WL Jr, Douglas WG, Anderson GR, Stoler DL (2003) Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 25:662-670
19. Yu Y, Zhang C, Zhou G, Wu S, Qu X, Wei H, Xing G, Dong C, Zhai Y, Wan J, Ouyang S, Li L, Zhang S, Zhou K, Zhang Y, Wu C, He F (2001) Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res 11:1392-1403